Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Curegene logo — Advancing antiviral, cardiovascular, and cerebrovascular tre...

Curegene

Advancing antiviral, cardiovascular, and cerebrovascular treatments with leading prodrug and nucleic acid drug technologies.

Founded 2018 Series B Total: $100.00M Health Care, Health and Wellness

General Information

Company Name Curegene
Founded Year 2018
Industries Health Care, Health and Wellness
Funding Stage Series B
Social

Get notified when Curegene moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Curegene

Curegene is a biotech startup established in 2018 with a strong focus on developing innovative treatments for anti-viral, cardiovascular, and cerebrovascular diseases. The company's commitment is emphasized in its slogan, "Advancing antiviral, cardiovascular, and cerebrovascular treatments with leading prodrug and nucleic acid drug technologies." At the forefront of its industry, Curegene has achieved significant advancements in small molecules and nucleic acid pharmaceuticals, positioning itself as a leader in targeted prodrug and nucleic acid drug technologies. The latest milestone for Curegene came with a notable CNY100.00M Series B investment on 31 January 2024. The funding round saw participation from prominent investors, including Taiyu Investment, Hankang Capital, Honghai Chuangjian, TaiKun Fund, and Lichen Capital. As the company continues to attract substantial investments and build strategic partnerships, it demonstrates the industry's recognition of its potential and capabilities. Specializing in the Health Care and Health and Wellness sectors, Curegene's innovative approach and promising developments have captured the attention of investors and industry experts, making it a compelling venture for those seeking opportunities in the biotech and pharmaceutical space. With its pioneering technologies and strategic investments, Curegene is poised to make significant contributions to the advancement of treatments in its targeted disease areas.

Taxonomy: pharmaceuticals, prodrug technology, nucleic acid drugs, antiviral treatments, cardiovascular treatments, cerebrovascular treatments, small molecules, medical research, drug development

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 5
Investor
•••• •••• 		31 Jan 2024

Curegene Alternatives & Competitors

Curegene vs
Chuangjian Medical
Chuangjian Medical

Redefining medicine through pioneering protein- and nucleic acid-based treatments.

Series B
Biopharma, Biotechnology
Curegene vs
Rongcan Bio
Rongcan Bio

Completing the entire nucleic acid industry cycle, from sequence design to drug delivery.

Series A
Biopharma, Biotechnology
Curegene vs
Hongene Biotech Corporation
Hongene Biotech Corporation United States

A manufacturer with state-of-art facilities in the fields of nucleosides, nucleotides and phosphoram...

57 employees
Biotechnology, Manufacturing

FAQ About Curegene

Advancing antiviral, cardiovascular, and cerebrovascular treatments with leading prodrug and nucleic acid drug technologies.
Curegene was founded in 2018.
Curegene operates in the following industries: Health Care, Health and Wellness.
Curegene has completed 1 funding round, raising a total of $100.00M. The latest funding stage is Series B.
Top alternatives and competitors to Curegene include Chuangjian Medical, Rongcan Bio, Hongene Biotech Corporation, PURMX Therapeutics,Inc., MJJ Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Curegene and Chuangjian Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Curegene and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy